|
VNDA Vanda Pharmaceuticals Inc. 1347178 |
| Balance Sheet |
|
Current Assets
|
$293,169,000.00 |
|
Assets
|
$433,525,000.00 |
|
Current Liabilities
|
$135,582,000.00 |
|
Liabilities
|
$152,760,000.00 |
|
Equity
|
$280,765,000.00 |
|
Shares Out
|
60135062.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-50,218,000.00 |
|
Investing Cash Flow
|
$20,234,000.00 |
| Market Analysis |
Market Cap
|
$311,499,621.16 |
|
Price
|
$5.06 |
|
BVPS
|
4.67 |
|
PB
|
1.11 |
|
EPS
|
-0.82 |
|
PS
|
1.81 |
|
FCF
|
$-50,439,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:28 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-11 |
-2.39 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-0.82 |
|
| Jul |
Aug |
Sep |
|
|
2025-07-31 |
-0.46 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-29 |
-0.38 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VNDA documents filed with the SEC.
VNDA Filings
Clear
